Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503
Source abstract
Abstract
Notoginsenoside R1 (NGR1) is a major bioactive ingredient of Radix notoginseng that has promise in treating several diabetes-related diseases, like diabetic nephropathy and diabetic cardiomyopathy. This work is designed to explore if NGR1 has potential in treating diabetic peripheral neuropathy (DPN). A cell model of DPN was made by stimulating RSC96 cells with high glucose. The effects of NGR1 preconditioning were examined by conducting CCK-8 assay, flow cytometry, ROS assay and Western blot. The downstream effector and signalling of NGR1 were then explored by qRT-PCR and Western blot. High glucose incubation led to cell viability loss, apoptosis facilitation, caspase-3 and PARP cleavage, and ROS generation of RSC96 cells. Meanwhile, expression of NGF and BDNF was declined by high glucose. Preconditioning NGR1 significantly protected RSC96 cells against high glucose-evoked damage. And NGR1 prevented high glucose-induced expression of miR-503. The beneficial functions of NGR1 towards high glucose-injured RSC96 cells were impeded by miR-503 overexpression. Further, NGR1 activated PI3K/AKT and β-catenin signalling through a miR-503-dependent way. This paper illustrated the neuroprotective and neurotrophic function of NGR1 in RSC96 cells. The beneficial function may due to its regulation on miR-503 expression and the downstream signalling such as PI3K/AKT and β-catenin.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: MicroRNA in disease regulation · Ginseng Biological Effects and Applications · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Endocrinology, Jining No. 1 People’s Hospital
References (42)
Show source-provided references
1. 10.1111/j.1526-4637.2010.01012.x10.1111/j.1526-4637.2010.01012.x ↗
2. 10.1038/srep4140110.1038/srep41401 ↗
3. 10.1159/00044405610.1159/000444056 ↗
4. 10.1038/s41572-019-0092-110.1038/s41572-019-0092-1 ↗
5. 10.1124/jpet.114.21875010.1124/jpet.114.218750 ↗
6. 10.1097/SHK.0b013e3181ceede410.1097/SHK.0b013e3181ceede4 ↗
7. 10.3109/10715762.2014.88511710.3109/10715762.2014.885117 ↗
8. 10.3892/ijmm.2017.286410.3892/ijmm.2017.2864 ↗
9. 10.12659/MSM.91151210.12659/MSM.911512 ↗
10. 10.1007/s11064-018-2538-310.1007/s11064-018-2538-3 ↗
11. 10.2174/187152731466615022514152110.2174/1871527314666150225141521 ↗
12. 10.3390/molecules2402024710.3390/molecules24020247 ↗
13. 10.3389/fphar.2018.0122710.3389/fphar.2018.01227 ↗
14. 10.2147/DDDT.S14970010.2147/DDDT.S149700 ↗
15. 10.2337/db16-118210.2337/db16-1182 ↗
16. 10.1097/WNR.000000000000105810.1097/WNR.0000000000001058 ↗
17. 10.1161/CIRCULATIONAHA.110.95232510.1161/CIRCULATIONAHA.110.952325 ↗
18. 10.1186/s12902-019-0371-610.1186/s12902-019-0371-6 ↗
19. 10.1016/j.nano.2019.01.00710.1016/j.nano.2019.01.007 ↗
20. 10.1007/s11064-017-2333-610.1007/s11064-017-2333-6 ↗
21. 10.1016/j.jpain.2019.04.01010.1016/j.jpain.2019.04.010 ↗
22. 10.1016/j.mcn.2007.10.00410.1016/j.mcn.2007.10.004 ↗
23. Du W, Wang N, Li F, et al. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy. FASEB J: Off Publ Federation Am Soc Exp Biol. 2019;33(7):8008-8021.
24. 10.4103/1673-5374.24559010.4103/1673-5374.245590 ↗
25. 10.7150/ijms.2969210.7150/ijms.29692 ↗
26. 10.1016/j.intimp.2014.06.01810.1016/j.intimp.2014.06.018 ↗
27. 10.18632/oncotarget.2429510.18632/oncotarget.24295 ↗
28. 10.1016/j.neulet.2015.01.04810.1016/j.neulet.2015.01.048 ↗
29. 10.1007/s10571-006-9096-y10.1007/s10571-006-9096-y ↗
30. 10.3892/mmr.2016.595210.3892/mmr.2016.5952 ↗
31. 10.1038/s41598-017-16373-710.1038/s41598-017-16373-7 ↗
32. 10.1371/journal.pone.009984910.1371/journal.pone.0099849 ↗
33. 10.1016/j.cbi.2019.05.05310.1016/j.cbi.2019.05.053 ↗
34. 10.1080/21691401.2019.157318910.1080/21691401.2019.1573189 ↗
35. 10.1159/00049567710.1159/000495677 ↗
36. Chen L, Gong HY, Xu L. PVT1 protects diabetic peripheral neuropathy via PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2018;22(20):6905–6911.
37. 10.2174/138161282366617021015014710.2174/1381612823666170210150147 ↗
38. 10.1016/j.jsbmb.2017.10.00810.1016/j.jsbmb.2017.10.008 ↗
39. 10.2174/15672021179549540210.2174/156720211795495402 ↗
40. 10.1038/s41598-017-11904-810.1038/s41598-017-11904-8 ↗
41. 10.1186/s12935-019-0875-110.1186/s12935-019-0875-1 ↗
42. 10.1007/s10103-018-2636-010.1007/s10103-018-2636-0 ↗